Digital pathology improves lab efficiency by lowering costs, reducing turnaround times, and providing users with subject-matter expertise. Patients and clinicians rely on lab data to make diagnostic choices, therefore lab efficiency improvements are critical. Diagnostic tests must be carried out and reported in a timely and correct manner. In addition, having web-based access to digitised slides cuts down on shipping costs and pathologists' travel time. As a result of the COVID-19 outbreak, lockdowns and social distance limitations have been established. As a result of these constraints, demand for digital pathology technologies has increased, which allow pathologists to assess diagnostic results remotely for primary diagnosis.
The COVID-19 epidemic is expected to have a beneficial impact on the worldwide Digital Pathology Market, fueling its expansion. The US Food and Drug Administration's Center for Devices and Radiological Health issued an enforcement policy for remote digital pathology devices, which are meant for pathologists, clinical laboratories, and drug administration personnel. As a result, the rising use of digital pathology systems for diagnosis has increased, which is expected to drive the digital pathology market throughout the forecast period. As a result, new product approvals and new innovations by key players are propelling the market forward. During the projected period, however, the high cost of digital pathology systems is expected to limit market expansion.
Read more @ https://cmiaspireblog.blogspot.com/2022/03/digital-pathology-market-by-product.html
